Introduction
The pandemic of coronavirus diseases 19 (COVID-19), caused by the severe acute respiratory syndrome novel virus (SARS-CoV-2), continues despite initiation of the global vaccination1. Besides its exhausting length and overwhelming burden, the number of reports of patients with SARS-CoV-2 reinfection is increasing2-4. A systematic review of the literature estimated the incidence rate of the recurrent SARS‑CoV‑2 positivity to be 14.8%5.
The majority of the case reports on this topic have described a more severe clinical presentation for the reinfection compared to the initial encounter. However, to the best of our knowledge, there is no report to present a case of reinfection with a different clinical manifestation from the initial episode.